Mi Xiaohui X - OmicsDI

Show results for

Transcriptomics (1)
Unknown (1)
Metabolomics (1)

Organisms

Rattus norvegicus (1)

Repository

biostudies-arrayexpress (1)
MetaboLights (1)

Technology Type

Mass spectrometry (1)

Instrument Platform

Liquid Chromatography MS - negative - hilic (1)
Liquid Chromatography MS - positive - hilic (1)

Publication Date

2014 (1)
2023 (1)

CHEBI ID

CHEBI:10106 (1)
CHEBI:10117 (1)
CHEBI:10217 (1)
CHEBI:110179 (1)
CHEBI:111 (1)
CHEBI:113545 (1)
CHEBI:116314 (1)
CHEBI:12350 (1)
CHEBI:1296 (1)
CHEBI:12962 (1)
CHEBI:131342 (1)
CHEBI:132138 (1)
CHEBI:132150 (1)
CHEBI:132223 (1)
CHEBI:132230 (1)
CHEBI:132403 (1)
CHEBI:132477 (1)
CHEBI:132582 (1)
CHEBI:132793 (1)
CHEBI:132983 (1)
CHEBI:133596 (1)
CHEBI:133600 (1)
CHEBI:133662 (1)
CHEBI:134468 (1)
CHEBI:134689 (1)
CHEBI:134856 (1)
CHEBI:135051 (1)
CHEBI:135574 (1)
CHEBI:135611 (1)
CHEBI:135976 (1)

Metabolite Name

(+)-alpha-tocopherol (1)
(-)-perillyl alcohol (1)
(-)-quebrachitol (1)
(-)-riboflavin (1)
(.+/-.)-cromakalim (1)
(2r,3r,4s,5s,6r)-2-[1,7-bis(4-hydroxyphenyl)heptan-3-yloxy]-6-(hydroxymethyl)oxane-3,4,5-triol (1)
(2r,3s,4s,5r,6r)-5-[(2s,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-2-(hydroxymethyl)-6-(2-phenylethoxy)oxane-3,4-diol (1)
(2s,3r,5r,10r,13r,14s,17s)-2,3,14-trihydroxy-10,13-dimethyl-17-[(2r,3r,5r)-2,3,6-trihydroxy-5,6-dimethylheptan-2-yl]-2,3,4,5,9,11,12,15,16,17-decahydro-1h-cyclopenta[a]phenanthren-6-one (1)
(3r,7r,9s,10s,12s,13r,14s,17r)-17-((2r)-6,7-dihydroxy-6-methylheptan-2-yl)-10,13-dimethylhexadecahydro-1h-cyclopenta[a]phenanthrene-3,7,12-triol (1)
(r)-butyrylcarnitine (1)
.delta.-dodecalactone (1)
1,2-di-(9z,12z,15z-octadecatrienoyl)-sn-glycero-3-phosphocholine (1)
1,2-diamino-2-methylpropane (1)
1,2-diarachidonoyl-sn-glycero-3-phosphocholine (1)
1,2-dihexadecanoyl-sn-glycerol (1)
1,2-dihydroxyheptadec-16-en-4-yl acetate (1)
1,2-dihydroxyheptadec-16-yn-4-yl acetate (1)
1,2-dilinoleoyl-sn-glycero-3-phosphoethanolamine (1)
1,2-dilinoleoylglycerol (1)
1,2-dioleoyl-sn-glycero-3-phosphatidylcholine (1)
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-n,n-dimethyl (1)
1,2-dioleoyl-sn-glycerol (1)
1,2-dipalmitoleoyl-sn-glycero-3-phosphocholine (1)
1,2-dipentadecanoyl-sn-glycero-3-phosphocholine (1)
1,6-anhydro-beta-d-glucose (1)
1-(1z-hexadecenyl)-sn-glycero-3-phosphocholine (1)
1-(1z-octadecenyl)-2-(4z,7z,10z,13z,16z,19z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine (1)
1-(1z-octadecenyl)-sn-glycero-3-phosphocholine (1)
1-aminocyclopropanecarboxylic acid (1)
1-behenoyl-2-hydroxy-sn-glycero-3-phosphocholine (1)

Study type

Transcription profiling by array (1)

Release Date

2014 (1)
2025 (1)

Previous page
1 / 1
You're on page 1
Next page

Sort by:

Relevance

Page size

A network pharmacology study of Chinese Medicine QSYQ to reveal its underlying multi-compound, multi-target, multi-pathway mode of action

Chinese medicine is a complex system guided by traditional Chinese medicine (TCM) theories, which has proven to be especially effective in treating chronic and complex diseases. However, the underlying modes of action (MOA) are not always systematically investigated. Herein, a systematic study was d...

ORGANISM(S): Rattus norvegicus

2014-01-17 | E-GEOD-54134 | biostudies-arrayexpress

Insights into the blood, gut, and oral microbiomes in Chinese patients with myocardial infarction: a case-control study.

Not available

S-EPMC12008866 | biostudies-literature

Integrated metabolomics and network pharmacology investigation of cardioprotective effects of myricetin after 1-week high-intensity exercise

Cardiovascular adverse effects caused by high-intensity exercise (HIE) have become a public health problem of widespread concern. As a phytochemical with potential therapeutic effects, the therapeutic effect and metabolic regulation mechanism of myricetin have rarely been studied. In this study, ...

2023-03-06 | MTBLS5608 | MetaboLights

Previous page
1 / 1
You're on page 1
Next page